Depression with comorbid juvenile-onset fibromyalgia syndrome novel treatment plan using interpersonal psychotherapy: A case report

Samah H. Alkhawashki,Norah Algarzae
DOI: https://doi.org/10.1097/md.0000000000039505
IF: 1.6
2024-11-08
Medicine
Abstract:Fibromyalgia syndrome (FMS) is a chronic debilitating syndrome that affects 2% to -4% of people. [ 1 ] In FMS, there is a lack of primary tissue damage with evident neuropathic pain described by patients as dull/deep/aching or burning/tingling with varying locations and levels of intensity. [ 2 , 3 ] Juvenile-onset fibromyalgia (JFM) is a form of FMS that is a complicated chronic disease that remains hard to understand in adolescence. FMS comorbidities include cognitive functions and psychological stressors such as anxiety and depression. [ 4 , 5 ] FMS is described as masked depression. [ 6 ] Depression occurs in FMS patients 40% to 80% of the time, [ 6 ] due to the shared symptoms and pathophysiology. [ 7 ] Similar physiological pathways in FMS and depression are due to the commonality in the initiation of the acute stress response. Once activated, the acute stress response activates the hypothalamic-pituitary-adrenal (HPA) axis. [ 7 ] In addition to activating the HPA axis, pain pathways from FMS and depression can also activate the autonomic nervous system (ANS). [ 2 ] In FMS, the activation of the HPA axis and ANS causes the release of corticotrophin-releasing hormone causing the release of cortisol thus initiating a reaction with the neurotransmitter system and activating the "fight-or-flight" response. [ 2 , 7 ] Similarly, in depression, the activation of the HPA axis leads to an increased level of circulating inflammatory cytokines, further contributing to depression progression by decreasing serotonin levels. [ 8 ] Globally, the activation of the HPA axis is linked to adulthood onset of depression; however, there is less information on its mechanism of action in adolescents. [ 9 ] A systemic review and meta-analysis show that raised levels of cortisol due to the HPA axis in adolescents is a risk factor for depression. [ 8 ] The average age of adolescents diagnosed with JFM is between 13 and 15, depending on socio-cultural background. [ 10 ] JFM has yet to be fully understood, specifically how chronic pain, and social, and physical distress are life-altering for adolescents. [ 11 ] The likelihood of depression incidences in the beginning stages of life increases as time goes on, we have a perfect window for targeting JFM and depression for new methods of treatment. [ 8 ]
medicine, general & internal
What problem does this paper attempt to address?